Welcome to Inogen's Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, February 24, 2026. I would now like to turn the call ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...

Medical Technology company Inogen Inc (NASDAQ:INGN) reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents. The ...

Income tax impact of adjustments represents the tax impact related to the non-GAAP adjustments listed above and reflects an effective tax rate of 0% for 2025 and 2024.

Inogen, Inc. INGN incurred an adjusted loss per share of 2 cents for third-quarter 2025, which was narrower than the adjusted loss per share of 11 cents in the year-ago period and the Zacks Consensus ...

Needham analyst Mike Matson upgraded Inogen, Inc (NASDAQ:INGN) from Hold to Buy, with a price forecast of $12. On May 7, the company reported its first-quarter results. Total revenue in the quarter ...

Welcome to Inogen’s First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following the management’s prepared remarks, we will hold a Q&A session ...